Journal of Korean society of Dental Hygiene (한국치위생학회지)

Korean Society of Dental Hygiene (한국치위생학회)
권호 표지
DOI QR코드

DOI QR Code

The effect of eugenol on the induction of apoptosis in HSC-2 human oral squamous cell carcinoma

사람구강편평상피암세포에서 유지놀에 의한 세포자멸사 유도 효과

  • Kim, Yong-Ho (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Park, Bong-Soo (Department of Oral Anatomy, School of Dentistry, Pusan National University)
  • 김용호 (부산대학교 치의학전문대학원 구강해부학교실) ;
  • 박봉수 (부산대학교 치의학전문대학원 구강해부학교실)
  • Received : 2015.03.02
  • Accepted : 2015.05.26
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Oropharynx tumors(oral cancer), are caused by tobacco, alcohol consumption, and high-risk human papillomavirus(HPV) infection. Oral squamous cell carcinoma(OSCC) is the most common type of oral cancer and frequently arises from the mucosa of the oropharynx and oral cavity. Despite advances in the diagnosis and treatment(chemotherapy, radiotherapy, and surgery) of oral cancer, over the past two decades, the overall survival rates remains at about 60%. Methods: We pretreated HSC-2 cells with various doses of exposed the cells to eugenol and then we measured cell viability by MTT assay. Results: Cell proliferation was markedly inhibited after eugenol treatment compared to the control. The majority of HSC-2 cells in the control groups showed normal morphology with round regular nuclei. In contrast, apoptotic bodies were seen in the 0.5 mM, 1 mM, 2 mM group. However, the pretreatment with eugenol increased HSC-2 cells apoptosis according to dose-dependency. PI staining quantitatively confirmed the anti-apoptotic effects of propofol. The expression levels of cleaved caspase 3, and Bak significantly increased in HSC-2 cells. Conclusions: These findings indicate that eugenol could be a potential anti-cancer agent for human OSCC and provide valuable data for the development of a novel anticancer strategy.

Keywords

References

  1. Chen SF, Nien S, Wu CH, Liu CL, Chang YC, Lin YS. Reappraisal of the anticancer efficacy of quercetin in oral cancer cells. J Chin Med Assoc 2013; 76(3): 146-52. https://doi.org/10.1016/j.jcma.2012.11.008
  2. Zhang X, Liu Y, Gilcrease MZ, Yuan XH, Clayman GL, Adler-Storthz K, et al. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 2002; 95(8): 1663-72. http://dx.doi.org/10.1002/cncr.10837.
  3. Chen YJ, Chang JT, Liao CT, Wang HM, Yen TC, Chiu CC, et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 2008; 99(8): 1507-14. http://dx.doi.org/10.1111/j.1349-7006.2008.00863.x.
  4. Adelstein DJ, Li Y, Adams GL, Wagner H, Jr, Kish JA, Ensley JF. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21(1): 92-8. http://dx.doi.org/10.1200/jco.2003.01.008.
  5. Boulikas T, Vougiouka M. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review). Oncol Rep 2004; 11(3): 559-95. http://dx.doi.org/10.3892/or.11.3.559.
  6. Butler MS. The role of natural product chemistry in drug discovery. J Nat Prod 2004; 67(12): 2141-53. http://dx.doi.org/10.1021/np040106y.
  7. Sondak VK, Sabel MS, Mule JJ. Allogeneic and autologous melanoma vaccines: where have we been and where are we going?. Clin Cancer Res 2006; 12(7 Pt 2): 2337s-41s. http://dx.doi.org/10.1158/1078-0432.ccr-05-2555.
  8. Pramod K, Ansari SH, Ali J. Eugenol: a natural compound with versatile pharmacological actions. Nat Prod Commun 2010; 5(12): 1999-2006.
  9. Stich HF, Stich W, Lam PP. Potentiation of genotoxicity by concurrent application of compounds found in betel quid: arecoline, eugenol, quercetin, chlorogenic acid and Mn2+. Mutat Res 1981; 90(4): 355-63. http://dx.doi.org/10.1016/0165-1218(81)90058-6.
  10. Benencia F, Courreges MC. In vitro and in vivo activity of eugenol on human herpesvirus. Phytother Res 2000; 14(7): 495-500. http://dx.doi.org/10.1002/1099-1573(200011)14:7<495::aid-ptr650>3.0.co;2-8.
  11. Al-Sharif I, Remmal A, Aboussekhra A. Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation. BMC Cancer 2013; (1)3: 600. http://dx.doi.org/10.1186/1471-2407-13-600.
  12. Park BS, Song YS, Yee SB, Lee BG, Seo SY, Park YC, et al. Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis. Apoptosis 2005; 10(1): 193-200. http://dx.doi.org/10.1007/s10495-005-6074-7.
  13. Slamenova D, Horvathova E, Wsolova L, Sramkova M, Navarova J. Investigation of anti-oxidative, cytotoxic, DNA-damaging and DNA-protective effects of plant volatiles eugenol and borneol in human-derived HepG2, Caco-2 and VH10 cell lines. Mutat Res 2009; 677(1-2): 46-52. http://dx.doi.org/10.1016/j.mrgentox.2009.05.016.
  14. Okada N, Hirata A, Murakami Y, Shoji M, Sakagami H, Fujisawa S. Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression by eugenol-related compounds. Anticancer Res 2005; 25(5): 3263-9.
  15. Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. The Journal of biological chemistry 2005; 280(7): 5812-9. http://dx.doi.org/10.1074/jbc.m411429200.
  16. Pisano M, Pagnan G, Loi M, Mura ME, Tilocca MG, Palmieri G, et al. Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. Mol Cancer 2007; (6): 8.
  17. Lee AR, Park, SY, Lee, KH. The protective effect of coenzyme Q10 on cytotoxicity of regin monomer of odontoblast caused by TEGDMA. J Korean Soc Dent Hyg 2014; 14(5): 775-81. http://dx.doi.org/10.13065/jksdh.2014.14.05.775.
  18. Huh MK, Kim HJ. Antibacterial effect on leaf-extract from Nelumbo nucifera against oral microorganism. J Korean Soc Dent Hyg 2014; 14(1): 117-22. https://doi.org/10.13065/jksdh.2014.14.01.117
  19. Chen PN, Hsieh YS, Chiang CL, Chiou HL, Yang SF, Chu SC. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res 2006; 85(3): 220-5. http://dx.doi.org/10.1177/154405910608500303.
  20. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62(1): 10-29. http://dx.doi.org/10.3322/caac.20138.
  21. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108. http://dx.doi.org/10.3322/canjclin.52.1.23.
  22. Schneider-Stock R, Boltze C, Lasota J, Miettinen M, et al. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol 2003; 21(9): 1688-97. http://dx.doi.org/10.1200/jco.2003.08.101.
  23. Adams JM, Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 2007; 19(5): 488-96. http://dx.doi.org/10.1016/j.coi.2007.05.004.
  24. Jaganathan SK, Supriyanto E. Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells. Molecules 2012; 17(6): 6290-304. http://dx.doi.org/10.3390/molecules17066290.
  25. Yoo CB, Han KT, Cho KS, et al. Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Lett 2005; 225(1): 41-52. http://dx.doi.org/10.1016/j.canlet.2004.11.018.
  26. Kaur G, Athar M, Alam MS. Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Mol Carcinog 2010; 49(3): 290-301. http://dx.doi.org/10.1002/mc.20601.

Cited by

  1. Effects of Mothers Involved in Dental Health Program for Their Children vol.42, pp.7, 2012, https://doi.org/10.4040/jkan.2012.42.7.1050